Scinopharm Taiwan Ltd.
Records under this name other than the patents Scinopharm Taiwan Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
Back to Scinopharm Taiwan Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,765,370 | Inhibition-based high-throughput screen strategy for cell clones Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,933,196 | Peptide Chromatographic Purification Assisted by Combining of Solubility Parameter and Solution Conformation Energy Calculations Formerly held In force · High confidence | In force | High confidence | |
| US 8,835,179 | Real-Time Monitor Solid Phase Peptide Synthesis by Mass Spectrometry Formerly held Lapsed on the fee record Ended Sep 16, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 16, 2026 | Medium confidence |
| US 11,384,054 | Crystalline Form of Ivacaftor and a Process for Preparing the Same Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 8,710,221 | Process and intermediates for preparing lapatinib Lapsed on the fee record Ended Apr 29, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2026 | USPTO record |
| US 8,563,719 | Process and intermediates for preparing lapatinib Lapsed on the fee record Ended Oct 22, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 22, 2025 | USPTO record |
| US 8,481,728 | Process for preparing entecavir and its intermediates Lapsed on the fee record Ended Jul 9, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 9, 2025 | USPTO record |
| US 9,670,234 | Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy-cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs Lapsed on the fee record Ended Jun 6, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 6, 2025 | USPTO record |
| US 7,151,179 | Process for the preparation of 7-alkyl-10-hydroxy-20(S)-camptothecin Term ended Term ended Apr 4, 2025 · USPTO record | Term ended | Term ended Apr 4, 2025 | USPTO record |
| US 7,307,162 | Resolution of a narwedine amide derivative Term ended Term ended Jan 29, 2025 · USPTO record | Term ended | Term ended Jan 29, 2025 | USPTO record |